The size of the North America Patient positioning systems Market is predicted at USD 394.66 million in 2022. It is estimated to be growing at a CAGR of 4.3% to reach USD 487.13 million by 2027. North America had a dominant share of 35.4% in 2022 due to the increasing prevalence of chronic and lifestyle-related diseases and sophisticated healthcare infrastructure. Besides, the local presence of major players in the US market, such as Hill-Rom Holdings, Inc.; Stryker Corporation; Medline Industries; Skytron, LLC; and SchureMed, Expected to Drive Growth in the North American Patient Positioning Systems Market.
Patient positioning systems are the medical devices used to handle the patient during surgery or to keep the patient in a specific position. These devices are also used during cancer therapy/ radiation therapy or precision therapy and create an advantage for both patients and doctors. This equipment helps in enhancing the comfort levels of a patient post-operation. It reduces pain and stimulates the healing process, and a wide variety of these apparatus are available in the market.
Technological advancements in sensors such as fiber optic technology, cancer tracking sensors, and MEMS sensors are expected to drive market growth. These systems help keep patients in a comfortable and stable position during radiation therapy and during treatment administration. The increasing prevalence of cancer further complements the development of this market. The increase in the geriatric population in the region, the daily increase in the competitive landscape, and technological advancements are the primary reasons and factors driving the market dynamics. Technical advances in patient positioning systems, the number of surgeries increasing, and resentment over the prevalence of disease and rising government funding drive market growth.
The main opportunities for market players are an investment for improvement in various market sectors. However, the factor that can hamper the market's growth is the risk to patient safety. Life-related issues are significant factors that can slow down the development of the market.
This research report on the North America Patient Positioning Systems Market has been segmented and sub-segmented into the following categories:
By End User:
The growing geriatric population, increased prevalence of cancer, increased awareness of the patient population, and increased spending on diagnostic procedures are expected to drive the Patient Positioning Systems market during the forecast period. Through the Patient Positioning System, hospitals try to provide the best healthcare facilities and prevent further bodily harm, including nerve damage, among others. An increasing number of surgeries due to the rising prevalence of chronic diseases has driven the market demand for Patient Positioning Systems. According to the World Cancer Report released by WHO, the prevalence of cancer is expected to reach 15 million new cases per year by 2020. The National Cancer Institute has estimated that 1,755,340 new cancer cases may have been diagnosed in the United States alone by 2020. This steady increase in the disease's prevalence is a driver for R & D investments in the 'industry.
Companies playing a dominant role in the North America Patient Positioning Systems Market profiled in this report are Getinge AB (Sweden), Hill-Rom, Inc. (U.S.), Stryker Corporation (U.S.), Steris Plc. (U.S.), Span-America Medical Systems, Inc. (U.S.), Skytron, LLC. (U.S.), Elekta AB (Sweden), C-RAD (Sweden), LEONI AG (Germany), and Mizuho OSI (U.S.).
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org